chr2-71552987-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001130987.2(DYSF):​c.1807-24C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0405 in 1,613,810 control chromosomes in the GnomAD database, including 2,825 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.084 ( 1071 hom., cov: 33)
Exomes 𝑓: 0.036 ( 1754 hom. )

Consequence

DYSF
NM_001130987.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.77

Publications

2 publications found
Variant links:
Genes affected
DYSF (HGNC:3097): (dysferlin) The protein encoded by this gene belongs to the ferlin family and is a skeletal muscle protein found associated with the sarcolemma. It is involved in muscle contraction and contains C2 domains that play a role in calcium-mediated membrane fusion events, suggesting that it may be involved in membrane regeneration and repair. In addition, the protein encoded by this gene binds caveolin-3, a skeletal muscle membrane protein which is important in the formation of caveolae. Specific mutations in this gene have been shown to cause autosomal recessive limb girdle muscular dystrophy type 2B (LGMD2B) as well as Miyoshi myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2008]
DYSF Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuromuscular disease caused by qualitative or quantitative defects of dysferlin
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • autosomal recessive limb-girdle muscular dystrophy type 2B
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • distal myopathy with anterior tibial onset
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital myopathy, Paradas type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Miyoshi myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-71552987-C-G is Benign according to our data. Variant chr2-71552987-C-G is described in ClinVar as Benign. ClinVar VariationId is 259066.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.217 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DYSFNM_001130987.2 linkc.1807-24C>G intron_variant Intron 19 of 55 ENST00000410020.8 NP_001124459.1
DYSFNM_003494.4 linkc.1753-24C>G intron_variant Intron 19 of 54 ENST00000258104.8 NP_003485.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DYSFENST00000410020.8 linkc.1807-24C>G intron_variant Intron 19 of 55 1 NM_001130987.2 ENSP00000386881.3
DYSFENST00000258104.8 linkc.1753-24C>G intron_variant Intron 19 of 54 1 NM_003494.4 ENSP00000258104.3

Frequencies

GnomAD3 genomes
AF:
0.0834
AC:
12692
AN:
152156
Hom.:
1071
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.221
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0403
Gnomad ASJ
AF:
0.0216
Gnomad EAS
AF:
0.0306
Gnomad SAS
AF:
0.0600
Gnomad FIN
AF:
0.00913
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.0311
Gnomad OTH
AF:
0.0735
GnomAD2 exomes
AF:
0.0434
AC:
10847
AN:
250010
AF XY:
0.0413
show subpopulations
Gnomad AFR exome
AF:
0.228
Gnomad AMR exome
AF:
0.0230
Gnomad ASJ exome
AF:
0.0193
Gnomad EAS exome
AF:
0.0285
Gnomad FIN exome
AF:
0.00714
Gnomad NFE exome
AF:
0.0308
Gnomad OTH exome
AF:
0.0361
GnomAD4 exome
AF:
0.0361
AC:
52715
AN:
1461536
Hom.:
1754
Cov.:
30
AF XY:
0.0364
AC XY:
26480
AN XY:
727040
show subpopulations
African (AFR)
AF:
0.229
AC:
7676
AN:
33470
American (AMR)
AF:
0.0257
AC:
1147
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.0218
AC:
569
AN:
26128
East Asian (EAS)
AF:
0.0274
AC:
1089
AN:
39692
South Asian (SAS)
AF:
0.0582
AC:
5019
AN:
86216
European-Finnish (FIN)
AF:
0.00815
AC:
435
AN:
53354
Middle Eastern (MID)
AF:
0.0775
AC:
447
AN:
5768
European-Non Finnish (NFE)
AF:
0.0302
AC:
33539
AN:
1111828
Other (OTH)
AF:
0.0463
AC:
2794
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
2473
4945
7418
9890
12363
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1386
2772
4158
5544
6930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0835
AC:
12715
AN:
152274
Hom.:
1071
Cov.:
33
AF XY:
0.0805
AC XY:
5993
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.221
AC:
9180
AN:
41514
American (AMR)
AF:
0.0403
AC:
616
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0216
AC:
75
AN:
3472
East Asian (EAS)
AF:
0.0307
AC:
159
AN:
5178
South Asian (SAS)
AF:
0.0600
AC:
290
AN:
4830
European-Finnish (FIN)
AF:
0.00913
AC:
97
AN:
10622
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.0311
AC:
2117
AN:
68038
Other (OTH)
AF:
0.0737
AC:
156
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
554
1108
1662
2216
2770
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0245
Hom.:
24
Bravo
AF:
0.0912
Asia WGS
AF:
0.0690
AC:
241
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Distal myopathy with anterior tibial onset Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive limb-girdle muscular dystrophy type 2B Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Miyoshi muscular dystrophy 1 Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
13
DANN
Benign
0.59
PhyloP100
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2303595; hg19: chr2-71780117; COSMIC: COSV50449313; API